Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001817229-20-000001
Filing Date
2020-07-10
Accepted
2020-07-10 14:00:03
Documents
1
Effectiveness Date
2020-07-10
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9027
  Complete submission text file 0001817229-20-000001.txt   10079
Mailing Address 215 FIRST STREET SUITE 430 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 430 CAMBRIDGE MA 02142 617-655-6580
Vor Biopharma Inc. (Filer) CIK: 0001817229 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-370729 | Film No.: 201022757